4.2 Abstract in Atti di convegno

4.2 Abstract in Atti di convegno: [3021] Home page tipologia

Sfoglia

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 821 a 840 di 3.021

Comprehensive genome-wide profile of regional gains and losses in multiple myeloma using array-CGH: The 1q21 amplification and potential role of the BCL-9 gene in multiple myeloma pathogenesis

2004-01-01 Carrasco, R; Tonon, G; Brennan, C; Protopopov, A; Sinha, R; Feng, B; Leo, C; Zhang, Yy; Zhang, J; Zhan, Fh; Protopopova, M; Mitsiades, C; Munshi, N; Chin, L; Bergsagel, P; Kuehl, M; Shaughnessy, J; Anderson, K; Depinho, R

The role of consolidation radiotherapy in the management of stage III-IV diffuse large-cell lymphoma

1998-01-01 Ferreri, Ajm; Dell'Oro, S; Reni, M; Ceresoli, G; Cozzarini, C; Ponzoni, M; Locati, L; Villa, E

INHIBITION OF THE STK4 KINASE RESTORES THE HIPPO CO-FACTOR YAP1 AND INDUCES DNA-DAMAGE MEDIATED APOPTOSIS IN MULTIPLE MYELOMA CELLS

2014-01-01 Cottini, F; Hideshima, T; Xu, C; Ponzoni, M; Richardson, P; Cappio, Fc; Anderson, K; Tonon, G

A phase II trial of second-line therapy with trabectedin in metastatic pancreatic adenocarcinoma

2012-01-01 Belli, C; Cereda, S; Piemonti, L; D’Incalci, M; Allavena, P; Miggiano, C; Rognone, A; Fugazza, C; Longoni, S; Reni, M

The small-molecule VEGF-receptor inhibitor pazopanib (GW786034B) targets both tumor and endothelial cells in multiple myeloma

2006-01-01 Podar, K; Tonon, G; Sattler, M; Tai, Yt; Legouill, S; Yasui, H; Ishitsuka, K; Kumar, R; Pandite, Ln; Hideshima, T; Chauhan, D; Anderson, Kc

Hypothalamic-pitiuitary fnction in adults exposed to cranial irradiation for nonpituitary primary brain tumours: Preliminary report of one single center

2007-01-01 Motta, M; Perna, L; Losa, M; Lanzi, R; Madaschi, S; Bolognesi, A; Fiorino, C; Mazza, E; Guerra, C; Reni, M; Calandrino, R; Fazio, F

Mcl-1 Fragment Mcl-1128-350 Induces Inhibition of Multiple Myeloma Cell Proliferation and Apoptosis

2009-01-01 Podar, K; Zimmerhacki, A; Zhang, J; Tonon, G; Barila, D; Vallet, S; Sattler, M; Tai, Yt; Hideshima, T; Chauhan, D; Anderson, Kc

Salvage therapy in primary central nervous system lymphomas (PCNSL)

1998-01-01 Reni, M; Ferreri, Ajm; Truci, G; Canal, N; Villa, E

Expression of apoptotic markers in activated platelets is mediated in part by cathepsin

1998-01-01 Tonon, G; Luo, X; Chen, W; Shi, Y; Greco, N; Cattaneo, M; Jamieson, Ga

A randomized phase II trial of two different four-drug combinations in advanced pancreatic adenocarcinoma: cisplatin, capecitabine, gemcitabine plus either epirubicin or docetaxel

2009-01-01 Cereda, S; Reni, M; Rognone, A; Ghidini, M; Rezzonico, S; Passoni, P; Mazza, E; Belli, C; Zerbi, A; Villa, E

In vitro and in vivo activity of the VEGF inhibitor pazopanib

2007-01-01 Podar, K; Tonon, G; Sattler, M; Tai, Yt; Legouill, S; Yasui, H; Ishitsuka, K; Kumar, S; Kumar, R; Pandite, Ln; Hideshima, T; Chauhan, D; Anderson, Kc

Preliminary results of a phase II trial of PEFG (cisplatin, epirubicin, 5-fluorouracil and gemcitabine) in advanced gallbladder, biliary tract and ampulla of Vater adenocarcinoma

2002-01-01 Passoni, P; Reni, M; Zanello, A; Et, Al.

Profiling the Genomic Landscape at the Early Stages of CLL: Low Genomic Complexity and Paucity of Driver Mutations in MBL and Indolent CLL

2016-01-01 Agathangelidis, A; Ljungstrom, V; Scarfo, L; Fazi, C; Gounari, M; Pandzic, T; Sutton, La; Stamatopoulos, K; Tonon, G; Rosenquist, R; Ghia, P

Salvage therapy with temozolomide in immunocompetent patients with primary brain lymphoma

2001-01-01 Reni, M; Ferreri, Ajm; Candela, M; Abbadessa, A; Villa, E

Serine/Threonine Kinase STK4 Is a Novel Target in Myeloma

2014-01-01 Cottini, F; Hideshima, T; Buhrlage, S; Gray, Ns; Richardson, Pg; Tonon, G; Anderson, Kc

Second line treatment for primary central nervous system lymphomas (PCNSL)

2000-01-01 Reni, M; Ferreri, Ajm.

Exploiting oncogene-induced DNA replicative stress as synthetic lethal approach to target myeloma

2015-01-01 Cottini, F; Hideshima, T; Richardson, P; Anderson, K; Tonon, G

Intensified PEFG regimen in stage III-IV pancreatic adenocarcinoma: A phase I trial

2004-01-01 Dell'Oro, S; Reni, M; Bonetto, E; Panucci, Mg; Vigano, Mg; Zerbi, A; Balzano, G; Di Carlo, V; Staudacher, C; Villa, E

Identification of alternative forms of a P2X(1) receptor in platelets and megakaryocytic cells.

1997-01-01 Greco, Nj; Chen, Wd; Tonon, G

Preoperative chemoradiotherapy (CRT) for locally advanced rectal cancer

2006-01-01 Vitali, G; Ronzoni, M; Passoni, P; Staudacher, C; Di Palo, S; Cereda, S; Reni, M; Villa, E

Titolo	Data di pubblicazione	Autore(i)
Comprehensive genome-wide profile of regional gains and losses in multiple myeloma using array-CGH: The 1q21 amplification and potential role of the BCL-9 gene in multiple myeloma pathogenesis	1-gen-2004	Carrasco, R; Tonon, G; Brennan, C; Protopopov, A; Sinha, R; Feng, B; Leo, C; Zhang, Yy; Zhang, J; Zhan, Fh; Protopopova, M; Mitsiades, C; Munshi, N; Chin, L; Bergsagel, P; Kuehl, M; Shaughnessy, J; Anderson, K; Depinho, R
The role of consolidation radiotherapy in the management of stage III-IV diffuse large-cell lymphoma	1-gen-1998	Ferreri, Ajm; Dell'Oro, S; Reni, M; Ceresoli, G; Cozzarini, C; Ponzoni, M; Locati, L; Villa, E
INHIBITION OF THE STK4 KINASE RESTORES THE HIPPO CO-FACTOR YAP1 AND INDUCES DNA-DAMAGE MEDIATED APOPTOSIS IN MULTIPLE MYELOMA CELLS	1-gen-2014	Cottini, F; Hideshima, T; Xu, C; Ponzoni, M; Richardson, P; Cappio, Fc; Anderson, K; Tonon, G
A phase II trial of second-line therapy with trabectedin in metastatic pancreatic adenocarcinoma	1-gen-2012	Belli, C; Cereda, S; Piemonti, L; D’Incalci, M; Allavena, P; Miggiano, C; Rognone, A; Fugazza, C; Longoni, S; Reni, M
The small-molecule VEGF-receptor inhibitor pazopanib (GW786034B) targets both tumor and endothelial cells in multiple myeloma	1-gen-2006	Podar, K; Tonon, G; Sattler, M; Tai, Yt; Legouill, S; Yasui, H; Ishitsuka, K; Kumar, R; Pandite, Ln; Hideshima, T; Chauhan, D; Anderson, Kc
Hypothalamic-pitiuitary fnction in adults exposed to cranial irradiation for nonpituitary primary brain tumours: Preliminary report of one single center	1-gen-2007	Motta, M; Perna, L; Losa, M; Lanzi, R; Madaschi, S; Bolognesi, A; Fiorino, C; Mazza, E; Guerra, C; Reni, M; Calandrino, R; Fazio, F
Mcl-1 Fragment Mcl-1128-350 Induces Inhibition of Multiple Myeloma Cell Proliferation and Apoptosis	1-gen-2009	Podar, K; Zimmerhacki, A; Zhang, J; Tonon, G; Barila, D; Vallet, S; Sattler, M; Tai, Yt; Hideshima, T; Chauhan, D; Anderson, Kc
Salvage therapy in primary central nervous system lymphomas (PCNSL)	1-gen-1998	Reni, M; Ferreri, Ajm; Truci, G; Canal, N; Villa, E
Expression of apoptotic markers in activated platelets is mediated in part by cathepsin	1-gen-1998	Tonon, G; Luo, X; Chen, W; Shi, Y; Greco, N; Cattaneo, M; Jamieson, Ga
A randomized phase II trial of two different four-drug combinations in advanced pancreatic adenocarcinoma: cisplatin, capecitabine, gemcitabine plus either epirubicin or docetaxel	1-gen-2009	Cereda, S; Reni, M; Rognone, A; Ghidini, M; Rezzonico, S; Passoni, P; Mazza, E; Belli, C; Zerbi, A; Villa, E
In vitro and in vivo activity of the VEGF inhibitor pazopanib	1-gen-2007	Podar, K; Tonon, G; Sattler, M; Tai, Yt; Legouill, S; Yasui, H; Ishitsuka, K; Kumar, S; Kumar, R; Pandite, Ln; Hideshima, T; Chauhan, D; Anderson, Kc
Preliminary results of a phase II trial of PEFG (cisplatin, epirubicin, 5-fluorouracil and gemcitabine) in advanced gallbladder, biliary tract and ampulla of Vater adenocarcinoma	1-gen-2002	Passoni, P; Reni, M; Zanello, A; Et, Al.
Profiling the Genomic Landscape at the Early Stages of CLL: Low Genomic Complexity and Paucity of Driver Mutations in MBL and Indolent CLL	1-gen-2016	Agathangelidis, A; Ljungstrom, V; Scarfo, L; Fazi, C; Gounari, M; Pandzic, T; Sutton, La; Stamatopoulos, K; Tonon, G; Rosenquist, R; Ghia, P
Salvage therapy with temozolomide in immunocompetent patients with primary brain lymphoma	1-gen-2001	Reni, M; Ferreri, Ajm; Candela, M; Abbadessa, A; Villa, E
Serine/Threonine Kinase STK4 Is a Novel Target in Myeloma	1-gen-2014	Cottini, F; Hideshima, T; Buhrlage, S; Gray, Ns; Richardson, Pg; Tonon, G; Anderson, Kc
Second line treatment for primary central nervous system lymphomas (PCNSL)	1-gen-2000	Reni, M; Ferreri, Ajm.
Exploiting oncogene-induced DNA replicative stress as synthetic lethal approach to target myeloma	1-gen-2015	Cottini, F; Hideshima, T; Richardson, P; Anderson, K; Tonon, G
Intensified PEFG regimen in stage III-IV pancreatic adenocarcinoma: A phase I trial	1-gen-2004	Dell'Oro, S; Reni, M; Bonetto, E; Panucci, Mg; Vigano, Mg; Zerbi, A; Balzano, G; Di Carlo, V; Staudacher, C; Villa, E
Identification of alternative forms of a P2X(1) receptor in platelets and megakaryocytic cells.	1-gen-1997	Greco, Nj; Chen, Wd; Tonon, G
Preoperative chemoradiotherapy (CRT) for locally advanced rectal cancer	1-gen-2006	Vitali, G; Ronzoni, M; Passoni, P; Staudacher, C; Di Palo, S; Cereda, S; Reni, M; Villa, E

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 821 a 840 di 3.021

Legenda icone

file ad accesso aperto
file disponibili sulla rete interna
file disponibili agli utenti autorizzati
file disponibili solo agli amministratori
file sotto embargo
nessun file disponibile

Scopri

Accesso al fulltext

no fulltext2963
reserved35
open23